Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011, Article ID 815190, 11 pages
http://dx.doi.org/10.1155/2011/815190
Research Article

Physeal Bystander Effects in Rhabdomyosarcoma Radiotherapy: Experiments in a New Xenograft Model

1Department of Orthopaedic Surgery, Musculoskeletal Sciences Research Center, Institute for Human Performance, SUNY Upstate Medical University, 505 Irving Avenue, Syracuse, NY 13210, USA
2Imaging and Molecular Therapeutics Section, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B100, MSC 1002, Bethesda, MD 20892-1002, USA
3Department of Veterinary Clinical Sciences, Veterinary Medical Center, The Ohio State University, 601 Vernon Tharp Street, Columbus, OH 43210, USA

Received 28 November 2010; Accepted 20 January 2011

Academic Editor: Luca Sangiorgi

Copyright © 2011 Jason A. Horton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Toro, L. B. Travis, J. W. Hongyu, K. Zhu, C. D. M. Fletcher, and S. S. Devesa, “Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases,” International Journal of Cancer, vol. 119, no. 12, pp. 2922–2930, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Hays, “Rhabdomyosarcoma,” Clinical Orthopaedics and Related Research, no. 289, pp. 36–49, 1993. View at Google Scholar · View at Scopus
  3. R. B. Raney, J. R. Anderson, F. G. Barr et al., “Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V,” Journal of Pediatric Hematology/Oncology, vol. 23, no. 4, pp. 215–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. P. W. T. Pisters, B. O'Sullivan, and R. G. Maki, “Evidence-based recommendations for local therapy for soft tissue sarcomas,” Journal of Clinical Oncology, vol. 25, no. 8, pp. 1003–1008, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Butler, W. W. Robertson, W. Rate Jr., G. J. D'Angio, and D. S. Drummond, “Skeletal sequelae of radiation therapy for malignant childhood tumors,” Clinical Orthopaedics and Related Research, no. 251, pp. 235–240, 1990. View at Google Scholar · View at Scopus
  6. R. B. Marcus, “Current controversies in pediatric radiation oncology,” Orthopedic Clinics of North America, vol. 27, no. 3, pp. 551–557, 1996. View at Google Scholar · View at Scopus
  7. T. A. Damron, J. A. Spadaro, J. A. Horton, B. S. Margulies, J. A. Strauss, and C. E. Farnum, “Novel radioprotectant drugs for sparing radiation-induced damage to the physis,” International Journal of Radiation Biology, vol. 80, no. 3, pp. 217–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. T. A. Damron, B. S. Margulies, J. A. Strauss, K. O'Hara, J. A. Spadaro, and C. E. Farnum, “Sequential histomorphometric analysis of the growth plate following irradiation with and without radioprotection,” Journal of Bone and Joint Surgery. American, vol. 85, no. 7, pp. 1302–1313, 2003. View at Google Scholar · View at Scopus
  9. M. N. Yavuz, A. A. Yavuz, C. Ulku et al., “Protective effect of melatonin against fractionated irradiation-induced epiphyseal injury in a weanling rat model,” Journal of Pineal Research, vol. 35, no. 4, pp. 288–294, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. V. Céspedes, I. Casanova, M. Parreño, and R. Mangues, “Mouse models in oncogenesis and cancer therapy,” Clinical and Translational Oncology, vol. 8, no. 5, pp. 318–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. M. Kelly, R. B. Womer, P. H. B. Sorensen, Q. B. Xiong, and F. G. Barr, “Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma,” Journal of Clinical Oncology, vol. 15, no. 5, pp. 1831–1836, 1997. View at Google Scholar · View at Scopus
  12. R. S. Kerbel, “Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved,” Cancer Biology & Therapy, vol. 2, no. 4, pp. S134–S139, 2003. View at Google Scholar · View at Scopus
  13. T. Kubota, “Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation,” Journal of Cellular Biochemistry, vol. 56, no. 1, pp. 4–8, 1994. View at Google Scholar · View at Scopus
  14. C. Manzotti, R. A. Audisio, and G. Pratesi, “Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion,” Clinical and Experimental Metastasis, vol. 11, no. 1, pp. 5–14, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. R. S. Kerbel, I. Cornil, and D. Theodorescu, “Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis,” Cancer and Metastasis Reviews, vol. 10, no. 3, pp. 201–215, 1991. View at Google Scholar · View at Scopus
  16. L. W. K. Chung, C. L. Hsieh, A. Law et al., “New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions,” Urology, vol. 62, no. 5, pp. 44–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. I. J. Fidler, “Regulation of neoplastic angiogenesis,” Journal of the National Cancer Institute. Monographs, no. 28, pp. 10–14, 2001. View at Google Scholar · View at Scopus
  18. R. L. Jensen, D. Leppla, N. Rokosz, and R. D. Wurster, “Matrigel augments xenograft transplantation of meningioma cells into athymic mice,” Neurosurgery, vol. 42, no. 1, pp. 130–136, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. P. T. Tinkey, M. Milas, and R. E. Pollock, “Reliable establishment of human sarcoma xenografts in the nude rat,” Sarcoma, vol. 3, no. 2-3, pp. 129–133, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. L. White, K. Sterling-Levis, U. R. Kees, and V. Tobias, “Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model,” Journal of Clinical Neuroscience, vol. 8, no. 2, pp. 151–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. C. F. Hoyle and R. S. Negrin, “Engraftment of chronic myeloid leukemia in SCID mice,” Hematological Oncology, vol. 16, no. 3, pp. 87–100, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. K. E. Comstock, C. L. Hall, S. Daignault, S. A. Mandlebaum, C. Yu, and E. T. Keller, “A bioluminescent orthotopic mouse model of human osteosarcoma that allows sensitive and rapid evaluation of new therapeutic agents in vivo,” In Vivo, vol. 23, no. 5, pp. 661–668, 2009. View at Google Scholar · View at Scopus
  23. E. Michelini, L. Cevenini, L. Mezzanotte, and A. Roda, “Luminescent probes and visualization of bioluminescence,” Methods in Molecular Biology, vol. 574, pp. 1–13, 2009. View at Google Scholar · View at Scopus
  24. D. E. Jenkins, Y. Oei, Y. S. Hornig et al., “Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis,” Clinical and Experimental Metastasis, vol. 20, no. 8, pp. 733–744, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Lim, K. D. Modi, and J. Kim, “In vivo bioluminescent imaging of mammary tumors using IVIS spectrum,” Journal of Visualized Experiments, no. 26, article 1210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Seitz, S. W. Warmann, J. Fuchs et al., “Visualization of xenotransplanted human rhabdomyosarcoma after transfection with red fluorescent protein,” Journal of Pediatric Surgery, vol. 41, no. 8, pp. 1369–1376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. O. M. El-Badry, C. Minniti, E. C. Kohn, P. J. Houghton, W. H. Daughaday, and L. J. Helman, “Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors,” Cell Growth & Differentiation, vol. 1, no. 7, pp. 325–331, 1990. View at Google Scholar · View at Scopus
  28. M. Koleva, R. Kappler, M. Vogler, A. Herwig, S. Fulda, and H. Hahn, “Pleiotropic effects of sonic hedgehog on muscle satellite cells,” Cellular and Molecular Life Sciences, vol. 62, no. 16, pp. 1863–1870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Mao, K. L. Ligon, E. Y. Rakhlin et al., “A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway,” Cancer Research, vol. 66, no. 20, pp. 10171–10178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Strahm, A. D. Durbin, E. Sexsmith, and D. Malkin, “The CXCR4-SDF1α axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma,” Clinical and Experimental Metastasis, vol. 25, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Hirschfeld and L. Helman, “Diverse roles of insulin-like growth factors in pediatric solid tumors,” In Vivo, vol. 8, no. 1, pp. 81–90, 1994. View at Google Scholar · View at Scopus
  32. L. A. Damron, D. J. Dearth, R. L. Hoffman, and B. C. Clark, “Quantification of the corticospinal silent period evoked via transcranial magnetic stimulation,” Journal of Neuroscience Methods, vol. 173, no. 1, pp. 121–128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Vaupel, D. K. Kelleher, and O. Thews, “Modulation of tumor oxygenation,” International Journal of Radiation Oncology Biology Physics, vol. 42, no. 4, pp. 843–848, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. N. F. Kember, “An in vivo cell survival system based on the recovery of rat growth cartilage from radiation injury,” Nature, vol. 207, no. 4996, pp. 501–503, 1965. View at Publisher · View at Google Scholar · View at Scopus
  35. T. A. Damron, J. A. Horton, A. Naqvi et al., “Combination radioprotectors maintain proliferation better than single agents by decreasing early parathyroid hormone-related protein changes after growth plate irradiation,” Radiation Research, vol. 165, no. 3, pp. 350–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Walterhouse and A. Watson, “Optimal management strategies for rhabdomyosarcoma in children,” Pediatric Drugs, vol. 9, no. 6, pp. 391–400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. S. S. Donaldson, J. Meza, J. C. Breneman et al., “Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG,” International Journal of Radiation Oncology Biology Physics, vol. 51, no. 3, pp. 718–728, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. J. A. Spadaro, J. A. Horton, B. S. Margulies et al., “Radioprotectant combinations spare radiation-induced damage to the physis more than fractionation alone,” International Journal of Radiation Biology, vol. 81, no. 10, pp. 759–765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. T. A. Damron, M. Zhang, M. R. Pritchard et al., “Microarray cluster analysis of irradiated growth plate zones following laser microdissection,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 3, pp. 949–956, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Uhmann, U. Ferch, R. Bauer et al., “A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing,” International Journal of Oncology, vol. 27, no. 6, pp. 1567–1575, 2005. View at Google Scholar · View at Scopus
  41. H. Hahn, F. Nitzki, T. Schorban, B. Hemmerlein, D. Threadgill, and M. Rosemann, “Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2,” Genomics, vol. 84, no. 5, pp. 853–858, 2004. View at Publisher · View at Google Scholar · View at Scopus